Annals of Clinical and Translational Neurology · 2019 · 47 citations · 29 references
Life SciencesMolecular MedicineOphthalmologyGene ExpressionOcular DiseaseTranscriptomicsMicrorna BiologyMicrorna-mediated RegulationMyasthenia GravisRna-based DiagnosticsDisease-associated MicrornasLate-onset Myasthenia GravisMicrorna Dysregulation In DiseaseMicrorna Expression ProfilingMicrorna GenesMicrorna ProfilingOcular Myasthenia GravisTreatment Of Immunosuppression
Abstract Objective To determine a predictive factor for the risk of conversion from ocular myasthenia gravis ( OMG ) to generalized MG ( GMG ) in a prospective study. Methods RNA was isolated from serum samples and detection of micro RNA (mi RNA ) expression analyzed with qPCR . In the discovery set, 179 human mi RNA s were assayed for profiling of five OMG patients and four age‐ and gender‐matched healthy controls. Based on the specific accumulation pattern of 19 mi RNA s from the discovery set, in addition to mi RNA s previously found elevated in generalized MG ( GMG ; miR‐150‐5p and miR‐30e‐5p), 21 mi RNA s were subsequently analyzed in a validation cohort of 83 OMG patients (82 immunosuppression treatment naive; 49 male) within 3 months of diagnosis and at a follow‐up visit (median duration 28 months from first visit). Results Thirteen patients generalized 14.8 ± 12.0 months after the diagnosis and the majority (85%) belonged to the late onset MG group. Two mi RNA s were significantly higher in secondary GMG ( SGMG ) patients compared to OMG patients with late onset MG : miR‐30e‐5p (9.1 ± 0.5 vs. 6.3 ± 0.9; P < 0.0001) and miR‐150‐5p (7.4 ± 1.1 vs. 6.4 ± 1.1; P = 0.01). The sensitivity for miR‐30e‐5p in differentiating OMG and SGMG was 96% in all OMG patients and 100% in late onset OMG patients. Interpretation This is the first study to describe a potential predictive factor associated with the risk of generalization for patients with OMG . Raised levels (>8) of miR‐30e‐5p at initial presentation in patients with ocular MG symptoms, give a predictive cut‐off for subsequent generalization of 96–100%.
29
Prognosis of ocular myasthenia
Christopher T. Bever, Abdias V. Aquino, Audrey S. Penn et al. · Annals of Neurology · 1983 · 245 citations